Patents
Sitemap › C07 - Organic chemistry › C07K - Peptides › C07K 14 - Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
Patents for C07K 14 - Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof (291,526)
03/2009
03/12/2009WO2009030780A2 Non-natural proteinaceous scaffold made of three non-covalently associated peptides
03/12/2009WO2009030774A1 Truncated glp-1 derivatives and their therapeutical use
03/12/2009WO2009030771A1 Peptides derivatized with a-b-c-d- and their therapeutical use
03/12/2009WO2009030738A1 Glucagon-like peptide-1 derivatives and their pharmaceutical use
03/12/2009WO2009030679A1 Method for prolonging longevity
03/12/2009WO2009030500A1 Bone morphogenetic protein (bmp)-binding domains of proteins of the repulsive guidance molecule (rgm) protein family and functional fragments thereof, and use of same
03/12/2009WO2009030483A2 Calcium phosphate based delivery of growth and differentiation factors to compromised bone
03/12/2009WO2009030464A2 PRODUCTION AND USE OF VARIANTS OF HUMAN KUNITZ-TYPE PROTEASE INHIBITORS (hKTPI)
03/12/2009WO2009030163A1 Rice fat synthesizing related gene and its application
03/12/2009WO2009030094A1 Function and use of new lysosome-associated apoptosis-inducing protein containing ph and fyve domains (lapf)
03/12/2009WO2009030088A1 Function and use of a new human calcium/calmodulin-dependent protein kinase ii inhibitor
03/12/2009WO2009030066A1 Polyethylene glycol modified interferon alpha 2b and preparation method and applicatioins thereof
03/12/2009WO2009030065A1 INTERFERON ALPHA 2a MODIFIED BY POLYETHYLENE GLYCOL, ITS SYNTHESIS PROCESS AND APPLICATION
03/12/2009WO2009030040A1 Antimicrobial activity of bacteriocin-producing lactic acid bacteria
03/12/2009WO2009030031A1 Detection of toxigenic strains of clostridium difficile
03/12/2009WO2009030025A1 Porcine adeno-associated viruses
03/12/2009WO2009029991A1 Agents with angiogenic and wound healing activity
03/12/2009WO2009015247A3 Chimeric hiv antigens
03/12/2009WO2009014650A3 Recombinant vibrio cholerae exotoxins
03/12/2009WO2009013263A3 Plants having increased yield-related traits and a method for making the same
03/12/2009WO2009012143A3 Virus derived antimicrobial peptides
03/12/2009WO2009012026A3 Method of patterning a substrate
03/12/2009WO2009010826A3 Novel genes and methods of producing carotenoids
03/12/2009WO2009009084A3 Transcriptional engineering of lactobacillus
03/12/2009WO2009007120A3 Tnf superfamily collectin fusion proteins
03/12/2009WO2009004058A3 Novel prolactin compounds
03/12/2009WO2008157370A3 Secondary wall forming genes from maize and uses thereof
03/12/2009WO2008156829A3 Promoterless cassettes for expression of alphavirus structural proteins
03/12/2009WO2008152528A3 Method for the diagnosis or the screening of an arbovirus infection, reagents useful in said method and their applications
03/12/2009WO2008145721A3 N-terminal modification of polypeptides for protection against degradation by aminopeptidases
03/12/2009WO2008143713A3 Plant-made west nile virus (wnv) vaccines, vectors and plant codon optimized sequences
03/12/2009WO2008137108A3 Plants having enhanced yield-related traits and a method for making the same
03/12/2009WO2008135446A3 Klebsiella antigens
03/12/2009WO2008128701A3 Yeast expression systems
03/12/2009WO2008107900A3 Compositions and methods for modulating cell migration
03/12/2009WO2008051526A3 Bone morphogenetic proteins
03/12/2009WO2008040362A3 Generation of a cancer-specific immune response toward muc1 and cancer specific muc1 antibodies
03/12/2009WO2008015675A3 Polypeptides and polynucleotides encoding same and use thereof in the treatment of medical conditions associated with ischemia
03/12/2009WO2006137815A3 Method for purifying mixtures of immunoglobulin & albumin
03/12/2009US20090070895 Vacuole targeting peptide and nucleic acid
03/12/2009US20090070894 Plants having improved growth characteristics and methods for making the same
03/12/2009US20090070893 Soybean promoters and flower-preferred expression thereof in transgenic plants
03/12/2009US20090069552 Nucleic acids and proteins of insect Or83b odorant receptor genes and uses thereof
03/12/2009US20090069545 Insecticidal proteins; biological pest control; genetic molecules encoding plant floral defensin-like molecules and their use in generating transgenic plants having resistance or at least reduced sensitivity to plant pests
03/12/2009US20090069543 Factor IXa for the treatment of bleeding disorders
03/12/2009US20090069542 Process Of Extracting High Quality Proteins From Cereal Grains And Their ByProducts Using Acidic Medium And A Reducing Agent
03/12/2009US20090069541 Production of biopolymer film, fibre, foam and adhesive materials from soluble s-sulfonated keratin derivatives
03/12/2009US20090069540 Stretchable collagen material and manufacturing method and use thereof
03/12/2009US20090069539 Androgen regulated prostate specific (ARP4) polypeptide for use in diagnosis of prostatic cell proliferative disorders
03/12/2009US20090069535 Ligand (ACT-4-L) to a Receptor on the Surface of Activated CD4+ T-Cells
03/12/2009US20090069500 Label target and labeling reagents comprising rigid group backbones
03/12/2009US20090069274 Interferon-like protein zcyto21
03/12/2009US20090069264 Toxoplasma gondii nucleic acid molecules
03/12/2009US20090069259 Treatment of neuropathic pain with zinc finger proteins
03/12/2009US20090069258 Recombinant antibodies specific for beta-amyloid ends, dna encoding and methods of use thereof
03/12/2009US20090069244 Mutants of lactoferrin
03/12/2009US20090069241 Compositions and Methods for Use of Pigment Epithelial Derived Factor (PEDF) Peptide Fragments
03/12/2009US20090069238 Activatable clostridial toxins
03/12/2009US20090069237 Methods and compositions for treating conditions
03/12/2009US20090069236 PROCESS FOR THE PREPARATION OF HYPOALLERGENIC MAJOR BIRCH POLLEN ALLERGEN rBet v 1
03/12/2009US20090069234 Cell-permeable peptide inhibitors of the jnk signal transduction pathway
03/12/2009US20090069232 Glycosylation of molecules
03/12/2009US20090069230 Gdnf-derived peptides
03/12/2009US20090069225 Somatostatin analogues
03/12/2009US20090069216 Single-Chain Insulin Analogues and Pharmaceutical Formulations Thereof
03/12/2009US20090069215 Acylated Single Chain Insulin
03/12/2009US20090068737 Methods of inhibiting interleukin-17 receptor
03/12/2009US20090068733 T2R, a novel family of taste receptors
03/12/2009US20090068732 Directed evolution methods for improving polypeptide folding and solubility and superfolder fluorescent proteins generated thereby
03/12/2009US20090068722 produced by Paenibacillus polymyxa strain; for use in therapeutic feeds, reducing levels of colonization by target bacteria in poultry
03/12/2009US20090068717 In vivo incorporation of unnatural amino acids
03/12/2009US20090068704 Utilization of starch for biological production by fermentation
03/12/2009US20090068702 Method for producing a mucin-type glycoprotein
03/12/2009US20090068679 Binding partners of the placental growth factor, especially antibodies directed against the placental growth factor, and production and use thereof
03/12/2009US20090068663 predicting in an individual the likelihood of developing cancer; genotyping; familial adenomatous polyposis (FAP), attenuated FAP (AFAP), or hereditary non-polyposis colorectal cancer (HNPCC) syndrome
03/12/2009US20090068642 Composition and pharmacology of novel alpha6-containing nicotinic acetylcholine receptors
03/12/2009US20090068636 Viral protein
03/12/2009US20090068635 Indirectly labelled assay conjugates and methods of preparing and using same
03/12/2009US20090068337 Increased alpha-prime beta-conglycinin soybeans
03/12/2009US20090068250 Bioresorbable and biocompatible compounds for surgical use
03/12/2009US20090068235 Immunogenic cd19 peptides
03/12/2009US20090068234 Methods and compositions for the treatment and prevention of cancer
03/12/2009US20090068230 Enterohemorrhagic escherichia coli vaccine
03/12/2009US20090068229 Modified surface antigen
03/12/2009US20090068228 Vaccine; effective combination of pertussis filamentous hemagglutinin (FHA), pertactin (PRN, 69K-OMP), pertussis fimbriae (FIM) and pertussis toxin (PT); industrial scale purification
03/12/2009US20090068226 Bacterial superantigen vaccines
03/12/2009US20090068218 Antigens for Vaccination Against and Detection of Mycoplasma Suis
03/12/2009US20090068216 Modified surface antigen
03/12/2009US20090068215 Herpes simplex virus mutant icp0 protein
03/12/2009US20090068213 Immunogenic composition for early detection of dengue virus
03/12/2009US20090068212 Envelope protein for use as immunization tool in treatment and prevention of viral disease in crustaceans
03/12/2009US20090068211 Immunogenically-enhanced polypeptides and related methods
03/12/2009US20090068205 Antiproliferative agents; anticancer agents; composition comprising antagonist of a human ErbB4 receptor, in admixture with a pharmaceutically acceptable carrier; antagonist selected from group consisting of an antibody produced by a hybridoma selected from the group containing HER4.10H1.1A1
03/12/2009US20090068203 Methods for treating cardiovascular disease using a soluble CTLA4 Molecule
03/12/2009US20090068202 Humanized Anti-CD79B Antibodies and Immunoconjugates and Methods of Use
03/12/2009US20090068201 Methods of treatment using antibodies to neutrokine-alpha
03/12/2009US20090068188 C-C chemokine receptor 3 proteins
03/12/2009US20090068187 Novel 14275, 54420, 8797, 27439, 68730, 69112 and 52908 molecules and uses therefor
03/12/2009US20090068185 Asthma associated factors as targets for treating atopic allergies including asthma and related disorders
03/12/2009US20090068178 Compositions and Methods for the Treatment of Tumor of Hematopoietic Origin
1 ... 659 660 661 662 663 664 665 666 667 668 669 670 671 672 673 674 675 676 677 678 679 ... 2916